A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment
A Prospective, Observational Study, of a High Calorie, Higher Protein Peptide Based Oral Nutrition Supplement (ONS) With Medium Chain Triglycerides (MCTs) in a Malnourished Population With GI Tolerance Impairment
Sponsor: Abbott Nutrition
A observational or N/A phase clinical study on Malnutrition, this trial is completed. The trial is conducted by Abbott Nutrition and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2018 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Nutrition
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Badalona, Spain , Barakaldo, Spain , Cadiz, Spain , Córdoba, Spain , Granada, Spain , León, Spain , Madrid, Spain , Marbella, Spain , Murcia, Spain , Málaga, Spain and 7 more locations